Gene mutation r & d
Ended Awarded Last action
- Contract number
- N6264522F0121
- Awardee
-
Vysnova Partners, LLC UEI WG9BBL96G436
- Awarding agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Obligated
- $244,472
Award facts
- Opportunity
-
- Naval Medical Research Unit Two (NAMRU-2) Southeast Asia Biosurveillance and Epidemiology Research (SABER) II IDIQ Solicitation · N6264518R0046 · Posted Apr 23, 2018
- Contract value 100% obligated
- $244,472.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Bureau of Medicine and Surgery Department of the Navy, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Singapore
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $244,472 |
About this award
This $244,472 firm-fixed-price delivery order contract was awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Vysnova Partners, LLC, a health management and research services firm. The contract supports research and development activities related to gene mutation. This award is part of Vysnova Partners' portfolio of federal contracts, which includes multiple indefinite-delivery, indefinite-quantity (IDIQ) vehicles such as the Defense Security Cooperation Agency's $150 million assessment, monitoring, and evaluation IDIQ for global health and military readiness programs. Vysnova Partners provides a wide range of professional, scientific, and technical services to support medical research, clinical trials, disease surveillance, and global health initiatives for various Department of Defense and other federal agency clients. This contract does not have a socioeconomic set-aside designation.
Quick answers
Who was awarded contract N6264522F0121?
N6264522F0121 was awarded to Vysnova Partners, LLC by Naval Supply Systems Command (Department of the Navy) on September 18, 2022.
How much is contract N6264522F0121 worth?
The government has obligated $244,472 on N6264522F0121.
Which agency awarded contract N6264522F0121?
Naval Supply Systems Command (Department of the Navy) awarded N6264522F0121, with funding from Bureau of Medicine and Surgery (Department of the Navy).
Is contract N6264522F0121 an order under another contract?
Yes. N6264522F0121 is a delivery order under N6264518D5058, an indefinite delivery contract.
Was contract N6264522F0121 competed?
The extent of competition for N6264522F0121 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award